- Wondering if Globe Life at around US$137.62 is pricing in too much optimism or too much caution? This article walks through what that share price could imply about value.
- The stock has seen mixed recent returns, with a 2.4% decline over the last 7 days and a 4.6% decline over the last 30 days, while still showing 8.9% over 1 year, 31.9% over 3 years and 48.5% over 5 years.
- These moves are playing out against a backdrop of ongoing attention on US insurers, including Globe Life, as investors reassess risk, capital strength and the appeal of protection products in their portfolios. For you as a shareholder or potential buyer, that context matters when you compare the current share price with what different valuation methods suggest.
- Simply Wall St currently assigns Globe Life a value score of 6 out of 6, reflecting that the company screens as undervalued on all of its valuation checks. The sections that follow will unpack those methods and conclude with a broader way to think about what valuation really tells you.
Approach 1: Globe Life Excess Returns Analysis
The Excess Returns model asks a simple question: after paying shareholders a fair return for the risk they take, how much profit is left over each year, and what does that stream of profits suggest about value today.
For Globe Life, the key inputs are all about what the business earns on its equity base. Book Value sits at $75.54 per share and analysts point to a Stable EPS of $16.48 per share, based on weighted future Return on Equity estimates from 4 analysts. That implies an Average Return on Equity of 17.69% on a Stable Book Value of $93.17 per share, which is based on estimates from 5 analysts.
The model assumes shareholders require a Cost of Equity of $6.50 per share. Globe Life is estimated to generate an Excess Return of $9.98 per share above that. Feeding these inputs into the Excess Returns framework produces an intrinsic value of about $372.83 per share, which compares with the current price of around $137.62 and suggests the stock screens as 63.1% undervalued on this approach.
Result: UNDERVALUED
Our Excess Returns analysis suggests Globe Life is undervalued by 63.1%. Track this in your watchlist or portfolio, or discover 49 more high quality undervalued stocks.
Approach 2: Globe Life Price vs Earnings
For profitable companies like Globe Life, the P/E ratio is a useful yardstick because it links what you pay for each share directly to the earnings that support that share price.
What counts as a “normal” or “fair” P/E depends on how investors see growth potential and risk. Higher expected earnings growth or lower perceived risk can justify a higher P/E, while lower growth or higher risk usually pulls that multiple down.
Globe Life currently trades on a P/E of 9.32x. That sits below the Insurance industry average P/E of about 11.20x and below the peer group average of 12.18x. Simply Wall St’s Fair Ratio for Globe Life is 12.48x, which is its proprietary estimate of what a reasonable P/E could be once factors like earnings growth, profit margins, industry, market cap and company specific risks are all considered.
This Fair Ratio is more tailored than a simple comparison with industry and peers because it adjusts for the company’s own fundamentals rather than assuming every insurer should trade on the same multiple. With the actual P/E of 9.32x sitting below the Fair Ratio of 12.48x, the shares screen as undervalued on this metric.
Result: UNDERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.
Upgrade Your Decision Making: Choose your Globe Life Narrative
Earlier it was mentioned that there is an even better way to understand valuation. Narratives take the story you believe about Globe Life, link it to a set of revenue, earnings and margin estimates, turn that into a Fair Value, then keep it updated as news, earnings and guidance arrive. On Simply Wall St’s Community page you can compare different Narratives side by side so, for example, a bullish view that sees Globe Life’s Fair Value nearer US$199 and a more cautious view nearer US$145 lead to very different conclusions when you line those Fair Values up against the current share price.
Do you think there's more to the story for Globe Life? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com